Kim SU - Search Results

1

Personalized Antiviral Drug Selection in Patients With Chronic Hepatitis B Using a Machine Learning Model: A Multinational Study.

Hur MH, Park MK, Yip TC, Chen CH, Lee HC, Choi WM, Kim SU, Lim YS, Park SY, Wong GL, Sinn DH, Jin YJ, Kim SE, Peng CY, Shin HP, Chen CY, Kim HY, Lee HA, Seo YS, Jun DW, Yoon EL, Sohn JH, Ahn SB, Shim JJ, Jeong SW, Cho YK, Kim HS, Jang MJ, Kim YJ, Yoon JH, Lee JH. Hur MH, et al. Among authors: kim hy, kim yj, kim su, kim se, kim hs. Am J Gastroenterol. 2023 Nov 1;118(11):1963-1972. doi: 10.14309/ajg.0000000000002234. Epub 2023 Mar 7. Am J Gastroenterol. 2023. PMID: 36881437

2

Anti-hepatitis A virus seroprevalence among patients with chronic viral liver disease in Korea.

Kim DY, Ahn SH, Lee HW, Kim SU, Kim JK, Paik YH, Lee KS, Han KH, Chon CY. Kim DY, et al. Among authors: kim jk, kim su. Eur J Gastroenterol Hepatol. 2007 Nov;19(11):923-6. doi: 10.1097/MEG.0b013e3282efa432. Eur J Gastroenterol Hepatol. 2007. PMID: 18049159

3

How can we enhance the performance of liver stiffness measurement using FibroScan in diagnosing liver cirrhosis in patients with chronic hepatitis B?

Kim SU, Kim DY, Park JY, Lee JH, Ahn SH, Kim JK, Paik YH, Lee KS, Chon CY, Choi EH, Song KJ, Park YN, Han KH. Kim SU, et al. Among authors: kim jk, kim dy. J Clin Gastroenterol. 2010 Jan;44(1):66-71. doi: 10.1097/MCG.0b013e3181a95c7f. J Clin Gastroenterol. 2010. PMID: 19609218

4

Hepatocellular Carcinoma Risk Steadily Persists over Time Despite Long-Term Antiviral Therapy for Hepatitis B: A Multicenter Study.

Kim SU, Seo YS, Lee HA, Kim MN, Lee EJ, Shin HJ, Lee YR, Lee HW, Park JY, Kim DY, Ahn SH, Han KH, Um SH, Tak WY, Kweon YO, Kim BK, Park SY. Kim SU, et al. Among authors: kim mn, kim dy, kim bk. Cancer Epidemiol Biomarkers Prev. 2020 Apr;29(4):832-837. doi: 10.1158/1055-9965.EPI-19-0614. Epub 2020 Jan 27. Cancer Epidemiol Biomarkers Prev. 2020. PMID: 31988073

5

ALT Is Not Associated With Achieving Subcirrhotic Liver Stiffness and HCC During Entecavir Therapy in HBV-Related Cirrhosis.

Kim MN, Lee JS, Lee HW, Kim BK, Park JY, Kim DY, Ahn SH, Jang SY, Tak WY, Kweon YO, Park SY, Kim SU. Kim MN, et al. Among authors: kim su, kim dy, kim bk. Clin Gastroenterol Hepatol. 2023 Aug;21(9):2278-2287.e5. doi: 10.1016/j.cgh.2022.10.035. Epub 2022 Nov 11. Clin Gastroenterol Hepatol. 2023. PMID: 36375797

6

Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future.

Yu JH, Lee HA, Kim SU. Yu JH, et al. Among authors: kim su. Clin Mol Hepatol. 2023 Feb;29(Suppl):S136-S149. doi: 10.3350/cmh.2022.0436. Epub 2022 Dec 12. Clin Mol Hepatol. 2023. PMID: 36503205 Free PMC article. Review.

7

Sorafenib versus nivolumab after lenvatinib treatment failure in patients with advanced hepatocellular carcinoma.

Kim Y, Lee JS, Lee HW, Kim BK, Park JY, Kim DY, Ahn SH, Goh MJ, Kang W, Kim SU. Kim Y, et al. Among authors: kim su, kim dy, kim bk. Eur J Gastroenterol Hepatol. 2023 Feb 1;35(2):191-197. doi: 10.1097/MEG.0000000000002466. Epub 2022 Nov 1. Eur J Gastroenterol Hepatol. 2023. PMID: 36574310

8

CAGE-B and SAGE-B models better predict the hepatitis B virus-related hepatocellular carcinoma after 5-year entecavir treatment than PAGE-B.

Chon HY, Lee HA, Park SY, Seo YS, Kim SG, Lee CH, Lee TH, Ahn SH, Wong VW, Yip TC, Liang LY, Kim IH, Wong GL, Kim SU. Chon HY, et al. Among authors: kim ih, kim su, kim sg. J Dig Dis. 2023 Feb;24(2):113-121. doi: 10.1111/1751-2980.13172. Epub 2023 May 9. J Dig Dis. 2023. PMID: 37057685

9

Prevalence and risk factors for impaired renal function among Asian patients with nonalcoholic fatty liver disease.

Sun C, Goh GB, Chow WC, Chan WK, Wong GL, Seto WK, Huang YH, Lin HC, Lee IC, Lee HW, Kim SU, Wong VW, Fan JG. Sun C, et al. Among authors: kim su. Hepatobiliary Pancreat Dis Int. 2024 Jun;23(3):241-248. doi: 10.1016/j.hbpd.2023.08.004. Epub 2023 Aug 3. Hepatobiliary Pancreat Dis Int. 2024. PMID: 37620227

10

PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B.

Chun HS, Papatheodoridis GV, Lee M, Lee HA, Kim YH, Kim SH, Oh YS, Park SJ, Kim J, Lee HA, Kim HY, Kim TH, Yoon EL, Jun DW, Ahn SH, Sypsa V, Yurdaydin C, Lampertico P, Calleja JL, Janssen H, Dalekos GN, Goulis J, Berg T, Buti M, Kim SU, Kim YJ. Chun HS, et al. Among authors: kim yh, kim hy, kim yj, kim su, kim th, kim sh, kim j. J Hepatol. 2024 Jan;80(1):20-30. doi: 10.1016/j.jhep.2023.09.011. Epub 2023 Sep 19. J Hepatol. 2024. PMID: 37734683

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,005 results

Search Page